392 related articles for article (PubMed ID: 17548905)
21. A study of empyema thoracis and role of intrapleural streptokinase in its management.
Banga A; Khilnani GC; Sharma SK; Dey AB; Wig N; Banga N
BMC Infect Dis; 2004 Jun; 4():19. PubMed ID: 15222893
[TBL] [Abstract][Full Text] [Related]
22. Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan.
Lin YT; Chen TL; Siu LK; Hsu SF; Fung CP
Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1003-10. PubMed ID: 20505967
[TBL] [Abstract][Full Text] [Related]
23. Intrapleural urokinase treatment in children with complicated parapneumonic effusion.
Chen JP; Lue KH; Liu SC; Cheng SL; Sheu JN
Acta Paediatr Taiwan; 2006; 47(2):61-6. PubMed ID: 16927629
[TBL] [Abstract][Full Text] [Related]
24. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
25. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
26. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
27. The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review.
Nasralla A; Laing B; Turner SR
J Cardiothorac Surg; 2021 Aug; 16(1):236. PubMed ID: 34419110
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in parapneumonic effusion and empyema.
Chapman SJ; Davies RJ
Curr Opin Pulm Med; 2004 Jul; 10(4):299-304. PubMed ID: 15220756
[TBL] [Abstract][Full Text] [Related]
29. Medical management of parapneumonic pleural disease.
Barnes NP; Hull J; Thomson AH
Pediatr Pulmonol; 2005 Feb; 39(2):127-34. PubMed ID: 15573391
[TBL] [Abstract][Full Text] [Related]
30. [Drug treatment with fibrinolytics (corrected) of secondary empyema secondary to complicated parapneumonic effusion].
Diéguez EV; Alapont VM; San Román CG; Micó SV; Viguer CG
Cir Pediatr; 2009 Jul; 22(3):162-7. PubMed ID: 19957867
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
Wells RG; Havens PL
Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
[TBL] [Abstract][Full Text] [Related]
32. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of chest tube thoracostomy and video-assisted thoracoscopic surgery in empyema and parapneumonic effusion associated with pneumonia in children.
Aziz A; Healey JM; Qureshi F; Kane TD; Kurland G; Green M; Hackam DJ
Surg Infect (Larchmt); 2008 Jun; 9(3):317-23. PubMed ID: 18570573
[TBL] [Abstract][Full Text] [Related]
35. Routine use of pleural fluid cultures. Are they indicated? Limited yield, minimal impact on treatment decisions.
Jiménez D; Díaz G; García-Rull S; Vidal R; Sueiro A; Light RW
Respir Med; 2006 Nov; 100(11):2048-52. PubMed ID: 16584878
[TBL] [Abstract][Full Text] [Related]
36. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
[TBL] [Abstract][Full Text] [Related]
37. [Causes and risk factors of pleural empyema and complicated parapneumonic pleural effusion].
Zablockis R; Petruskeviciene R; Nargela RV
Medicina (Kaunas); 2010; 46(2):113-9. PubMed ID: 20440084
[TBL] [Abstract][Full Text] [Related]
38. Bacterial etiology of empyema thoracis and parapneumonic pleural effusion in Thai children aged less than 16 years.
Lochindarat S; Teeratakulpisarn J; Warachit B; Chanta C; Thapa K; Gilbert GL; Wangroongsarb Y; Pirçon JY; Van Dyke MK; Liu Y; Hausdorff WP
Southeast Asian J Trop Med Public Health; 2014 Mar; 45(2):442-54. PubMed ID: 24968687
[TBL] [Abstract][Full Text] [Related]
39. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults.
Porcel JM
Clin Respir J; 2018 Apr; 12(4):1361-1366. PubMed ID: 29087029
[TBL] [Abstract][Full Text] [Related]
40. [Fibrinolytics in the Treatment of Complicated Pleural Effusions].
Coelho A; Coelho M; Pereira J; Lavrador V; Morais L; Carvalho F
Acta Med Port; 2016 Nov; 29(11):711-715. PubMed ID: 28229836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
